Global health care specialists from coast to coast
Published in Quirk's Faces of Marketing Research August 2017
Research Partnership is celebrating 20 years in business this year with expansion across the U.S., opening new offices in San Francisco and New York. With headquarters in Philadelphia and a satellite office in Boston, Research Partnership is now expertly placed to support pharma from West to East coast. We shine a light on four of our key faces of research.
Navigating South Korea’s Healthcare Paradox
Published in eyeforpharma August 2017 by Marc Yates
In recent years, we have witnessed an explosion of interest among our pharmaceutical clients in conducting research in South Korea. Some emerging market analysts have suggested a ‘K’ should be added to BRIC, reflecting the country’s burgeoning economic status and its increasingly inclusion in global studies, not just regional Asia Pacific or emerging market studies. Indeed, there is ongoing debate about whether South Korea can still be considered ‘emerging’ as it is a growing player in the pharmaceutical industry in its own right.
As well as looking at South Korea’s healthcare outlook in more detail, in this article we also ask why the countries lies at the extremes of two conflicting global health indicators – longest life expectancy and highest suicide rates.
Demand assessment research
Head of Business Analytics Tom Nolte and Associate Director Will Tolley discuss demand assessment research including the various techniques and when in a product's stage of development should a demand assessment study be conducted.
Men vs Women in emerging markets
Our latest interactive infographic compares male vs female health characteristics in the BRIC emerging markets.
While a wide-range range of societal and economic factors influence health outcomes, one of the most significant factors is gender. In addition to overall morbidity and mortality, certain health issues are more commonly associated with one gender. But while biology plays a role, it is predominantly the way in which society structures and shapes men’s and women’s lives that result in health inequalities. Gender norms, roles and expectations vary between cultures, particularly in emerging markets, and affect the way in which health care is accessed. Our latest interactive infographic compares the lives of men vs women in the BRIC emerging markets, and explores how societal factors impact their respective health outcomes.
South Korea: The next global player?
In this paper, we will explore some of the key trends and outlooks for South Korea in more detail, including what lies behind its presence at the extremes of two conflicting global health indicators: longest life expectancy and highest suicide rates.
Over the past two decades South Korea has experienced rapid economic growth. Low unemployment, rising incomes and increased health insurance coverage have all contributed to the development of a robust healthcare sector and catalysed pharmaceutical sales. South Korea is currently the 13th largest pharmaceutical market in the world and the third largest in Asia, with predicted compound annual growth rate (CAGR) of 2.4%. increasing from US$18.6 billion in 2016 to US$20.4 billion by 2020.